Ledger entry · candidate
Semaglutide → COVID-19 — Audit-grade candidate (scan)
Drug: semaglutide · AE: COVID-19
Discovered via single-drug scan of semaglutide. PRR = 2.74 (95% CI 2.54–2.95), n = 670 cases. Pre-reg locked at submission time.
Disproportionality
- PRR: 2.7392424609620627
(95% CI 2.54–2.95)
- Yates χ2: 742.5235538666158
- Cases (case-drug + AE): n = 670
- Verdict:
PASSES_ALL_GATES — PRR=2.74 (95% CI 2.54–2.95), n=670 cases; flagged for clinical expert review, NOT for external escalation without manual verification
Top reactions in cohort
| MedDRA PT | n |
|---|
| No reactions surfaced in cohort. |
Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.